Search results for: 'gene industry forecast'

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

16 Aug 2022  |  North America  |  Market Research

Global Cell and Gene Therapy (CGT) Growth Opportunities

The Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain

Infographics

×

This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approaches as well as investments and regulations. The study segments the market by product (cell therapy, gene-mod...

This research service provides a comprehensive overview of the US C5ISR industry, offering industry segmentation, funding/spending analysis, and competitive assessment. The C5ISR industry, based on platform type, is categorized into: 1. Computers 2. Command and Control (C2) 3. Communications 4. Cyber 5. Intelligence, Surveillance, and Reconnaissan...

The Latin American automotive industry maintains its rising trend despite the severe effects of COVID-19 on local economies, international conflicts, inflation, exchange rates, and difficulties arising from credit accessibility. With 4.8 million units sold in 2023, the Latin American automotive industry will likely grow 8.2% in 2024. However, th...

The enactment of the One Big Beautiful Bill Act (OBBBA) marks a dramatic shift in US energy policy. The OBBA significantly scales back the Inflation Reduction Act (IRA) tax credit support for wind and solar power, eliminates residential clean energy credit, energy efficiency home improvement credit, and electric vehicle credits, while extending sup...

Fifth-generation (5G) technology represents a fundamental shift in communication network architectures and accelerates revenue potential through innovative services that 5G-enabled smartphones, tablets, laptops, and Internet of Things (IoT) devices facilitate. This breakthrough technology delivers a potent combination of network capabilities and fl...

The U.S. Gene Therapy Market report provides timely information on the emerging gene therapy market. The report examines the overall market in terms of the primary factors driving growth and addresses the key challenges facing the market.

An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...